Clinical Trials Browser

Phase 1/2 × Unknown × Steroids × Clear all

NCT03613428 2018-08-03

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma